Renal Advantage and Liberty Dialysis said the two privately held dialysis companies reached a deal described as a merger under a holding company, a spokesman said. Terms of the deal were not disclosed.
Dialysis companies reach merger agreement
Private-equity firms Bain Capital, KRG Capital Partners and Ignition Partners, investors in Liberty Dialysis, will continue to have a stake in the combined companies, said Todd Smith, a spokesman for the companies.
Liberty Dialysis, Mercer Island, Wash., was formed eight years ago and operates 112 dialysis clinics. Renal Advantage, a 5-year old company with financing from private-equity firm Welsh, Carson, Anderson & Stowe, operates 150 dialysis centers in 19 states and has annual revenue of $465 million. The deal is expected to close by year-end.
Smith said the two companies would continue to operate independently and retain their respective CEOs.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.